Literature DB >> 24464651

miR-20a promotes prostate cancer invasion and migration through targeting ABL2.

Xiao-Fei Qiang1, Zheng-Wei Zhang, Qian Liu, Nan Sun, Liang-Liang Pan, Jing Shen, Tong Li, Chen Yun, Hui Li, Li-Hua Shi.   

Abstract

The aberrant expression of microRNAs (miRNAs) has been found in various types of cancer. The present study found miR-20a was significantly up-regulated in prostate cancer compared with normal prostate tissues. Patients with a higher miR-20a expression had a Gleason score of 7-10 and shorter survival time. The transwell and wound healing assays revealed that blocking expression of miR-20a by miR-20a ASO suppresses the invasion and migration of PC-3 and DU145 cells in vitro and also inhibits tumor growth in vivo. Furthermore, we identified miR-20a directly targets the ABL family non-receptor tyrosine kinases ABL2 and negatively regulates the phosphorylation of its downstream gene p190RhoGAP. Knockdown of ABL2 promoted cell invasion and migration and we identified miR-20a-induced cell invasion and migration can be rescued by ABL2. In conclusion, our findings show that miR-20a significantly contributes to the progression of prostate cancer by targeting ABL2.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ABL2; INVASION; MIGRATION; PROSTATE CANCER; miR-20a; p190RhoGAP

Mesh:

Substances:

Year:  2014        PMID: 24464651     DOI: 10.1002/jcb.24778

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  40 in total

1.  The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.

Authors:  Wang-Yang Chen; Xiao-Juan Zhao; Zhi-Fu Yu; Fu-Lan Hu; Yu-Peng Liu; Bin-Bin Cui; Xin-Shu Dong; Ya-Shuang Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Design of a small molecule against an oncogenic noncoding RNA.

Authors:  Sai Pradeep Velagapudi; Michael D Cameron; Christopher L Haga; Laura H Rosenberg; Marie Lafitte; Derek R Duckett; Donald G Phinney; Matthew D Disney
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-11       Impact factor: 11.205

3.  Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.

Authors:  Pang-Ning Teng; Nicholas W Bateman; Guisong Wang; Tracy Litzi; Brian E Blanton; Brian L Hood; Kelly A Conrads; Wei Ao; Kate E Oliver; Kathleen M Darcy; William P McGuire; Keren Paz; David Sidransky; Chad A Hamilton; G Larry Maxwell; Thomas P Conrads
Journal:  Hum Cell       Date:  2017-03-01       Impact factor: 4.174

4.  Serum miR-20a is a promising biomarker for gastric cancer.

Authors:  Ruirui Yang; Yun Fu; Ying Zeng; Mengqin Xiang; Yufang Yin; Li Li; Haifan Xu; Jing Zhong; Xi Zeng
Journal:  Biomed Rep       Date:  2017-02-20

5.  EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.

Authors:  Rakshamani Tripathi; Zulong Liu; Rina Plattner
Journal:  Curr Pharmacol Rep       Date:  2018-07-23

6.  Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.

Authors:  Li Zhang; Ping Xiang; Xuan Han; Liyong Wu; Xuwen Li; Zhuyou Xiong
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  The role of microRNAs in gallbladder cancer.

Authors:  Ganghua Yang; Lei Zhang; Ruixiang Li; Lin Wang
Journal:  Mol Clin Oncol       Date:  2016-05-11

8.  Modeling human prostate cancer progression in vitro.

Authors:  Teresa T Liu; Jonathan A Ewald; Emily A Ricke; Robert Bell; Colin Collins; William A Ricke
Journal:  Carcinogenesis       Date:  2019-07-20       Impact factor: 4.944

9.  MicroRNA-20a-5p inhibits epithelial to mesenchymal transition and invasion of endometrial cancer cells by targeting STAT3.

Authors:  Yu Huang; Nian Yang
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 10.  Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade.

Authors:  Jillian Hattaway Luttman; Ashley Colemon; Benjamin Mayro; Ann Marie Pendergast
Journal:  Cell Commun Signal       Date:  2021-05-22       Impact factor: 7.525

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.